< Key Hightlight >

MARKET OUTLOOK

As per Triton’s research on the European non-PVC IV bags market, the market is predicted to thrive at a compound annual growth rate of 7.60% during the projected period 2021-2028. Germany, Italy, Spain, France, Russia, the United Kingdom, and Rest of Europe shape the region’s market.

In the United Kingdom, the adoption of new technical solutions for healthcare is mainly owing to rising disposable income, coupled with growing government healthcare spending. The recent assessments by various committees have increased focus on eliminating PVC-based medical devices use across the country. This step has led to an increase in the adoption of non-PVC IV bags. Further, the ban by the EU Commission on the use of PVC-based products in 2015 is another factor supporting the growth of the non-PVC IV bags market across the nation. 

On the other hand, malnutrition is among the highly prevalent conditions among the aging population in Italy. This condition arises due to financial constraints, a decrease in sensory function, oral health issues, and others. As per recent statistics, Italy has the largest percentage of the elderly population. This rise in the aging population is expected to increase the demand for non-PVC IV bags to offer nutritional diets to the elderly. Hence, as mentioned above, these factors are expected to propel the non-PVC IV bags market on a progressive path. 

COMPETITIVE OUTLOOK 

The renowned companies in the non-PVC IV bags market are Sealed Air, Pfizer Inc, Otsuka, Angiplast Pvt Ltd, Huaren Pharmaceutical, B Braun Melsungen AG, and Medipharmaplan.